Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A12 (FAM90A12) is part of the primate-specific FAM90A gene family that has expanded due to multiple gene duplication and genomic rearrangement events[1][5]. It encodes a predicted protein of 464 amino acids with a molecular mass of approximately 49.8 kDa[1]. While its primary sequence is catalogued and evidence exists for its transcript, there is no verified molecular function, disease association, or recognized pharmacological relevance[1][5][7]. The gene is mainly annotated in genomics databases as a result of sequence similarity; its copies are sometimes listed as putative or uncharacterized proteins and may also be classified as pseudogenes[1]. There are no structural family or domain assignments pointing to enzyme, receptor, transporter, or regulatory functions, and it is not considered a therapeutic target. This entry is typical for recently annotated or primate-specific gene duplicates with no functional data; most data are bibliographical, genomic, and refer to its gene family lineage[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A12 (FAM90A12).